N-[4-[2-(3-amino-6-bromopyrazin-2-yl)-2-oxoethyl]phenyl]sulfonylacetamide;N-[4-[2-[3-amino-6-(2-cyano-5-fluorophenyl)pyrazin-2-yl]-2-oxoethyl]phenyl]sulfonylacetamide;4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile

C48H44BBrF2N10O10S2 — CID 159882542

IUPACN-[4-[2-(3-amino-6-bromopyrazin-2-yl)-2-oxoethyl]phenyl]sulfonylacetamide;N-[4-[2-[3-amino-6-(2-cyano-5-fluorophenyl)pyrazin-2-yl]-2-oxoethyl]phenyl]sulfonylacetamide;4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile
SMILESCC(=O)NS(=O)(=O)c1ccc(CC(=O)c2nc(-c3cc(F)ccc3C#N)cnc2N)cc1.CC(=O)NS(=O)(=O)c1ccc(CC(=O)c2nc(Br)cnc2N)cc1.CC1(C)OB(c2cc(F)ccc2C#N)OC1(C)C
InChIInChI=1S/C21H16FN5O4S.C14H13BrN4O4S.C13H15BFNO2/c1-12(28)27-32(30,31)16-6-2-13(3-7-16)8-19(29)20-21(24)25-11-18(26-20)17-9-15(22)5-4-14(17)10-23;1-8(20)19-24(22,23)10-4-2-9(3-5-10)6-11(21)13-14(16)17-7-12(15)18-13;1-12(2)13(3,4)18-14(17-12)11-7-10(15)6-5-9(11)8-16/h2-7,9,11H,8H2,1H3,(H2,24,25)(H,27,28);2-5,7H,6H2,1H3,(H2,16,17)(H,19,20);5-7H,1-4H3
InChIKeyNTSABFCIDUEQAO-UHFFFAOYSA-N
MW1113.79 g/mol
LogP5.05
Rot. Bonds12

About N-[4-[2-(3-amino-6-bromopyrazin-2-yl)-2-oxoethyl]phenyl]sulfonylacetamide;N-[4-[2-[3-amino-6-(2-cyano-5-fluorophenyl)pyrazin-2-yl]-2-oxoethyl]phenyl]sulfonylacetamide;4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile

N-[4-[2-(3-amino-6-bromopyrazin-2-yl)-2-oxoethyl]phenyl]sulfonylacetamide;N-[4-[2-[3-amino-6-(2-cyano-5-fluorophenyl)pyrazin-2-yl]-2-oxoethyl]phenyl]sulfonylacetamide;4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile (PubChem CID 159882542) has the molecular formula C48H44BBrF2N10O10S2 and a molecular weight of 1113.79 g/mol. Its IUPAC name is N-[4-[2-(3-amino-6-bromopyrazin-2-yl)-2-oxoethyl]phenyl]sulfonylacetamide;N-[4-[2-[3-amino-6-(2-cyano-5-fluorophenyl)pyrazin-2-yl]-2-oxoethyl]phenyl]sulfonylacetamide;4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile.

Molecular Properties

Compound NameN-[4-[2-(3-amino-6-bromopyrazin-2-yl)-2-oxoethyl]phenyl]sulfonylacetamide;N-[4-[2-[3-amino-6-(2-cyano-5-fluorophenyl)pyrazin-2-yl]-2-oxoethyl]phenyl]sulfonylacetamide;4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile
PubChem CID159882542
Molecular FormulaC48H44BBrF2N10O10S2
Molecular Weight1113.79 g/mol
Exact Mass1112.19
IUPAC NameN-[4-[2-(3-amino-6-bromopyrazin-2-yl)-2-oxoethyl]phenyl]sulfonylacetamide;N-[4-[2-[3-amino-6-(2-cyano-5-fluorophenyl)pyrazin-2-yl]-2-oxoethyl]phenyl]sulfonylacetamide;4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile
SMILESCC(=O)NS(=O)(=O)c1ccc(CC(=O)c2nc(-c3cc(F)ccc3C#N)cnc2N)cc1.CC(=O)NS(=O)(=O)c1ccc(CC(=O)c2nc(Br)cnc2N)cc1.CC1(C)OB(c2cc(F)ccc2C#N)OC1(C)C
InChIInChI=1S/C21H16FN5O4S.C14H13BrN4O4S.C13H15BFNO2/c1-12(28)27-32(30,31)16-6-2-13(3-7-16)8-19(29)20-21(24)25-11-18(26-20)17-9-15(22)5-4-14(17)10-23;1-8(20)19-24(22,23)10-4-2-9(3-5-10)6-11(21)13-14(16)17-7-12(15)18-13;1-12(2)13(3,4)18-14(17-12)11-7-10(15)6-5-9(11)8-16/h2-7,9,11H,8H2,1H3,(H2,24,25)(H,27,28);2-5,7H,6H2,1H3,(H2,16,17)(H,19,20);5-7H,1-4H3
InChIKeyNTSABFCIDUEQAO-UHFFFAOYSA-N
XLogP5.05
TPSA330.26 Ų
H-Bond Donors4
H-Bond Acceptors18
Rotatable Bonds12
Heavy Atoms74
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001113.79
LogP ≤ 55.05
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze N-[4-[2-(3-amino-6-bromopyrazin-2-yl)-2-oxoethyl]phenyl]sulfonylacetamide;N-[4-[2-[3-amino-6-(2-cyano-5-fluorophenyl)pyrazin-2-yl]-2-oxoethyl]phenyl]sulfonylacetamide;4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[4-[2-(3-amino-6-bromopyrazin-2-yl)-2-oxoethyl]phenyl]sulfonylacetamide;N-[4-[2-[3-amino-6-(2-cyano-5-fluorophenyl)pyrazin-2-yl]-2-oxoethyl]phenyl]sulfonylacetamide;4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile?
The IUPAC name of N-[4-[2-(3-amino-6-bromopyrazin-2-yl)-2-oxoethyl]phenyl]sulfonylacetamide;N-[4-[2-[3-amino-6-(2-cyano-5-fluorophenyl)pyrazin-2-yl]-2-oxoethyl]phenyl]sulfonylacetamide;4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile (CID 159882542) is N-[4-[2-(3-amino-6-bromopyrazin-2-yl)-2-oxoethyl]phenyl]sulfonylacetamide;N-[4-[2-[3-amino-6-(2-cyano-5-fluorophenyl)pyrazin-2-yl]-2-oxoethyl]phenyl]sulfonylacetamide;4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile.
What is the SMILES notation for N-[4-[2-(3-amino-6-bromopyrazin-2-yl)-2-oxoethyl]phenyl]sulfonylacetamide;N-[4-[2-[3-amino-6-(2-cyano-5-fluorophenyl)pyrazin-2-yl]-2-oxoethyl]phenyl]sulfonylacetamide;4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile?
The canonical SMILES for N-[4-[2-(3-amino-6-bromopyrazin-2-yl)-2-oxoethyl]phenyl]sulfonylacetamide;N-[4-[2-[3-amino-6-(2-cyano-5-fluorophenyl)pyrazin-2-yl]-2-oxoethyl]phenyl]sulfonylacetamide;4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile is CC(=O)NS(=O)(=O)c1ccc(CC(=O)c2nc(-c3cc(F)ccc3C#N)cnc2N)cc1.CC(=O)NS(=O)(=O)c1ccc(CC(=O)c2nc(Br)cnc2N)cc1.CC1(C)OB(c2cc(F)ccc2C#N)OC1(C)C.
What is the InChIKey of N-[4-[2-(3-amino-6-bromopyrazin-2-yl)-2-oxoethyl]phenyl]sulfonylacetamide;N-[4-[2-[3-amino-6-(2-cyano-5-fluorophenyl)pyrazin-2-yl]-2-oxoethyl]phenyl]sulfonylacetamide;4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile?
The InChIKey is NTSABFCIDUEQAO-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H16FN5O4S.C14H13BrN4O4S.C13H15BFNO2/c1-12(28)27-32(30,31)16-6-2-13(3-7-16)8-19(29)20-21(24)25-11-18(26-20)17-9-15(22)5-4-14(17)10-23;1-8(20)19-24(22,23)10-4-2-9(3-5-10)6-11(21)13-14(16)17-7-12(15)18-13;1-12(2)13(3,4)18-14(17-12)11-7-10(15)6-5-9(11)8-16/h2-7,9,11H,8H2,1H3,(H2,24,25)(H,27,28);2-5,7H,6H2,1H3,(H2,16,17)(H,19,20);5-7H,1-4H3.
What are the key properties of N-[4-[2-(3-amino-6-bromopyrazin-2-yl)-2-oxoethyl]phenyl]sulfonylacetamide;N-[4-[2-[3-amino-6-(2-cyano-5-fluorophenyl)pyrazin-2-yl]-2-oxoethyl]phenyl]sulfonylacetamide;4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile?
N-[4-[2-(3-amino-6-bromopyrazin-2-yl)-2-oxoethyl]phenyl]sulfonylacetamide;N-[4-[2-[3-amino-6-(2-cyano-5-fluorophenyl)pyrazin-2-yl]-2-oxoethyl]phenyl]sulfonylacetamide;4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile has a molecular weight of 1113.79 g/mol, XLogP of 5.05, 12 rotatable bonds, 4 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-[2-(3-amino-6-bromopyrazin-2-yl)-2-oxoethyl]phenyl]sulfonylacetamide;N-[4-[2-[3-amino-6-(2-cyano-5-fluorophenyl)pyrazin-2-yl]-2-oxoethyl]phenyl]sulfonylacetamide;4-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile is sourced from PubChem (CID 159882542), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).